We are live on ! Find out more
MDGN.WS

MEDGENICS INC WT PUR COM EXP 03/31/16

Delisted

MDGN.WS was delisted on the 7th of April, 2016.

2 hedge funds and large institutions have $34K invested in MEDGENICS INC WT PUR COM EXP 03/31/16 in 2015 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

211% more capital invested

Capital invested by funds: $10.9K → $34K (+$23.1K)

0% more funds holding

Funds holding: 22 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
Holders Change %
0%
% of All Funds
0.05%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

Rank Fund Capital Flow
1
ICM
Ionic Capital Management
New York
+$31.9K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$9.73K
2
SM
Sabby Management
Florida
-$922
Name Holding Trade Value Shares
Change
Change in
Stake
ICM
1
Ionic Capital Management
New York
$34K +$31.9K +12,450 New
SM
2
Sabby Management
Florida
-$922 -1,271,240 Closed
UBS Group
3
UBS Group
Switzerland
-$9.73K -3,799 -99%

MDGN.WS Hedge Fund Activity: Q1 2015 in Review

2 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in MEDGENICS INC WT PUR COM EXP 03/31/16 (MDGN.WS) for Q1 2015, worth a combined $34K — up 211% from $10.9K a quarter earlier.

Fund positioning in MDGN.WS was balanced in Q1 2015: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 1 trimmed.

The largest buyer was Ionic Capital Management, opening a new position worth an estimated $31.9K. The largest seller was UBS Group, cutting an estimated $9.73K.

  • 2 institutional investors held MEDGENICS INC WT PUR COM EXP 03/31/16 (MDGN.WS) as of Q1 2015, unchanged from Q4 2014.
  • Funds reported $34K of MEDGENICS INC WT PUR COM EXP 03/31/16 stock for Q1 2015, up 211% quarter-over-quarter.
  • 1 fund opened new MEDGENICS INC WT PUR COM EXP 03/31/16 positions in Q1 2015 and 1 closed out, a net change of 0 holders.
  • The largest MEDGENICS INC WT PUR COM EXP 03/31/16 buyer in Q1 2015 was Ionic Capital Management, an estimated $31.9K added.
  • The largest MEDGENICS INC WT PUR COM EXP 03/31/16 seller in Q1 2015 was UBS Group, an estimated $9.73K sold.

Based on aggregated 13F filings for Q1 2015.